Gregory S. Weinstein was a consultant for Intuitive Surgical, Inc., which ended November 2011.
Original Article–Special Proceedings
Article first published online: 26 SEP 2012
Copyright © 2012 Wiley Periodicals, Inc.
Head & Neck
Volume 34, Issue 12, pages 1681–1703, December 2012
How to Cite
Adelstein, D. J., Ridge, J. A., Brizel, D. M., Holsinger, F. C., Haughey, B. H., O'Sullivan, B., Genden, E. M., Beitler, J. J., Weinstein, G. S., Quon, H., Chepeha, D. B., Ferris, R. L., Weber, R. S., Movsas, B., Waldron, J., Lowe, V., Ramsey, S., Manola, J., Yueh, B., Carey, T. E., Bekelman, J. E., Konski, A. A., Moore, E., Forastiere, A., Schuller, D. E., Lynn, J. and Ullmann, C. D. (2012), Transoral resection of pharyngeal cancer: Summary of a National Cancer Institute Head and Neck Cancer Steering Committee Clinical Trials Planning Meeting, November 6–7, 2011, Arlington, Virginia. Head Neck, 34: 1681–1703. doi: 10.1002/hed.23136
Harry Quon received an honorarium and has served as a consultant in he past to Intuitive Surgical, Inc.
Val J. Lowe has received surgical support from GE HealthCare, Siemens Molecular Imaging, and AVID Radiopharmaceuticals/Lilly.
- Issue published online: 17 NOV 2012
- Article first published online: 26 SEP 2012
- Manuscript Accepted: 2 JUL 2012
Recent advances now permit resection of many pharyngeal tumors through the open mouth, an approach that can greatly reduce the morbidity of surgical exposure. These transoral techniques are being rapidly adopted by the surgical community and hold considerable promise. On November 6–7, 2011, the National Cancer Institute sponsored a Clinical Trials Planning Meeting to address how to further investigate the use of transoral surgery, both in the good prognosis human papillomavirus (HPV)–initiated oropharyngeal cancers, and in those with HPV-unrelated disease. The proceedings of this meeting are summarized. © 2012 Wiley Periodicals, Inc. Head Neck, 2012